DDX53 and breast cancer: This antibody demonstrated that Ivermectin was indeed able to up-regulate exposure of CRT on the surface of live murine (4T1.2, CT26) as well as human (MDA-MB-231) breast cancer cells prior to apoptosis (Supplementary Figure 7).